Elelyso OverviewTaliglucerase alfa, commercially known as Elelyso, is a biopharmaceutical drug developed by Protalix and Pfizer. The drug, a recombinant glucocerebrosidase used to treat Gaucher's disease, was the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration. Each vial has 200 units of taliglucerase alfa. For 2016, Elelyso was ranked third for pharmaceuticals with the highest cost-per-patie...
Read more Elelyso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Taliglucerase_alfa
Recent Elelyso Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 200 units/vial
- Powder: 200 units/vial
NDC Database Records for Elelyso: (1 result)Sorted by National Drug Code
- 0069-0106 Elelyso 200 U/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc